FC2ブログ

バイオの戯言

ライフサイエンスに関する話題についてコメント(戯言?)を述べていくブログです。

【プレスリリースメモ】 RNAi関係 (2013.5.6)  

<Alnylam Pharmaceuticals>
Alnylam to Webcast Conference Call Discussing First Quarter 2013 Financial Results(2013.4.29)

<Antisense Therapeutics>
Appendix 4C Quarterly(2013.4.30)
ATL1102 for Multiple Sclerosis - Toxicology Study to commence(2013.5.1)

<Arrowhead Research>
Arrowhead Prices $36 Million Private Offering(2013.4.29)
Arrowhead to Report Fiscal 2013 Second Quarter Financial Results(2013.5.2)

<Dynavax Technologies>
Dynavax Names Eddie Gray as Chief Executive Officer and Member of the Board of Directors(2013.4.30)

<Galena Biopharma>
William L. Ashton Joins Galena Biopharma's Board of Directors(2013.5.1)

<Idera Pharmaceuticals>
Idera Pharmaceuticals Announces Pricing of Public Offering of Common Stock and Warrants(2013.5.1)

<Isis Pharmaceuticals>
Webcast Alert: Isis Pharmaceuticals' First Quarter 2013 Financial Results Conference Call(2013.5.2)

<Moderna Therapeutics>
Moderna welcomes Henri A. Termeer, former CEO of Genzyme, to its board of directors(2013.4.30)

<OncoGenex Technologies>
OncoGenex Announces that the Borealis-2™ Clinical Trial of OGX-427 in Previously Treated Metastatic Bladder Cancer is now Open for Enrollment(2013.4.30)
OncoGenex Announces Plans for the Initiation of the Rainier™ Clinical Trial Evaluating OGX-427 in Combination with ABRAXANE® plus Gemcitabine in Patients with Metastatic Pancreatic Cancer(2013.5.1)
OncoGenex Pharmaceuticals, Inc. Provides Clinical Development Program Overview and Reports Financial Results for First Quarter 2013(2013.5.2)

<RXi Pharmaceuticals>
RXi Pharmaceuticals Announces Investor and Analyst Symposium(2013.4.29)
RXi Pharmaceuticals to Present at the 2013 ARVO Annual Meeting(2013.4.30)

<Silence Therapeutics>
Result of EGM(2013.4.29)
Holding in Company(2013.5.2)
Holding in Company(2013.5.2)
Holding in Company(2013.5.2)
Holding in Company(2013.5.2)

<Valeant Pharmaceuticals>
Actavis Acquires Worldwide Rights for Valeant's Metronidazole 1.3% Vaginal Gel(2013.5.1)
Valeant Pharmaceuticals Reports 2013 First Quarter Financial Results(2013.5.2)
Valeant Pharmaceuticals Provides Efinconazole Update(2013.5.2)

<Vical>
Vical Announces News Release and Conference Call Schedule for First Quarter 2013 Financial Results(2013.5.2)

<アンジェスMG>
第24 回新株予約権(第三者割当て)(行使価額修正条項付)の発行及びコミットメント条項付き第三者割当て契約に関するお知らせ(2013.5.1)


スポンサーサイト
[ 2013/05/06 22:41 ] プレスリリース | TB(0) | CM(0)
コメントの投稿













管理者にだけ表示を許可する
最新ニュース
お気に入り
カレンダー(月別)
07 ≪│2018/08│≫ 09
- - - 1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31 -
特選品
特許関係の書籍-3
特許関係の書籍-2
特許関係の書籍-1
情報関係の書籍
月別アーカイブ
プロフィール

のぐひで

Author:のぐひで
FC2ブログへようこそ!